Nombre del producto:18-[[(1S)-1-carboxy-4-[2-[2-[2-[2-[2-[2-(2,5-dioxopyrrolidin-1-yl)oxy-2-oxo-ethoxy]ethoxy]ethylamino]-2-oxo-ethoxy]ethoxy]ethylamino]-4-oxo-butyl]amino]-18-oxo-octadecanoic acid

IUPAC Name:17-{[(1S)-1-carboxy-3-({2-[2-({[2-(2-{2-[(2,5-dioxopyrrolidin-1-yl)oxy]-2-oxoethoxy}ethoxy)ethyl]carbamoyl}methoxy)ethoxy]ethyl}carbamoyl)propyl]carbamoyl}heptadecanoic acid

CAS:1169630-40-3
Fórmula molecular:C39H66N4O15
Pureza:95%+
Número de catálogo:CM457576
Peso molecular:830.97

Unidad de embalaje Stock disponible Precio($) Cantidad
CM457576-100mg in stock ůNJǵǵ
CM457576-250mg in stock ƓNJǤů

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1169630-40-3
Fórmula molecular:C39H66N4O15
Punto de fusión:-
Código de sonrisas:OC(=O)CCCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)ON1C(=O)CCC1=O)C(O)=O
Densidad:
Número de catálogo:CM457576
Peso molecular:830.97
Punto de ebullición:
Nº Mdl:MFCD32704903
Almacenamiento:

Category Infos

Fatty Acid Modified Side Chains
Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.